STOCK TITAN
  1. Home
  2. Sec-filings
  3. CYDY
  4. [EFFECT] CytoDyn Inc. SEC Filing

[EFFECT] CytoDyn Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 16, 2025
Accession Number: 0001104659-25-120019
Submission Type: POS AM
CIK: 0001175680
Company Name: CytoDyn Inc.
File Number: 333-282000

Source: View Original Filing on SEC EDGAR

Stock CYDY logo
Cytodyn Inc

OTC:CYDY

CYDY Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

CYDY Latest News

Jan 27, 2026
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer
Dec 16, 2025
December 2025 Letter to Shareholders
Dec 8, 2025
CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium
Dec 1, 2025
CytoDyn Announces Resolution of Class Action Lawsuit
Nov 24, 2025
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium

CYDY Latest SEC Filings

Jan 9, 2026
[424B3] CytoDyn Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 9, 2026
[10-Q] CytoDyn Inc. Quarterly Earnings Report
Dec 22, 2025
[424B3] CytoDyn Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Dec 1, 2025
[8-K] CytoDyn Inc. Reports Material Event
Nov 21, 2025
[8-K] CytoDyn Inc. Reports Material Event

CYDY Stock Data

362.94M
1.27B
0.54%
0.03%
Biotechnology
Healthcare
Link
United States
Vancouver